[Acute myocardial infarction in Charleroi: evolution of risk factors and therapeutic practices]

Ann Cardiol Angeiol (Paris). 2013 Aug;62(4):233-40. doi: 10.1016/j.ancard.2013.04.016. Epub 2013 May 20.
[Article in French]

Abstract

Objectives: The aim of the study consists in analyzing the evolution of acute coronary risk factors as well as the 28 days case fatality and the therapeutic practices over 12 years of follow-up in Charleroi. The factors influencing the mortality of these patients are also investigated.

Methods: The Charleroi register of ischaemic cardiopathies is the oldest register of infarctions in the French-speaking community of Belgium. Analyses presented hereafter relate only patients in the 25-69-year age range over time from 1998 to 2009. Some analysis was extended to 25-74-year range. Treatment and risk factors evolutions over time were analysed using Chi(2) tests. Logistic regression was used to identify factors influencing 28 days mortality.

Results: The analysis shows a significant decline in 28 days mortality. A marked increase in the prevalence of hypertension and hypercholesterolemia is highlighted as well as an increase of utilization of percutaneous transluminal coronary angioplasty (PTCA) between 1998 and 2009. The use of ß-blockers and antiplatelet drugs remained fairly stable between 1998 and 2009 with approximately 75% and 90% of the patients treated, respectively. The factors associated with fatality were specifically age of patients, antecedents of diabetes and antecedents of myocardial infarction, hypercholesterolaemia as well as oral antiplatelet drugs, ß-blockers therapies and PTCA.

Conclusions: The evolution of the therapeutic data on AMI in this register confirms that PTCA becomes the main coronary reperfusion. Angiotensin-converting enzyme inhibitors were without effect on mortality.

Keywords: Acute myocardial infarction; Facteurs de risque; Infarctus du myocarde; MONICA; Register; Registre; Risk factors; Traitement; Treatment.

Publication types

  • Multicenter Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Angioplasty, Balloon, Coronary / mortality*
  • Angioplasty, Balloon, Coronary / statistics & numerical data*
  • Belgium / epidemiology
  • Diabetes Complications / epidemiology
  • Diabetes Complications / therapy
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / epidemiology
  • Hypertension / complications
  • Hypertension / epidemiology
  • Incidence
  • Male
  • Middle Aged
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / mortality*
  • Myocardial Infarction / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prevalence
  • Risk Factors
  • Sex Distribution
  • Smoking / adverse effects
  • Survival Rate
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Platelet Aggregation Inhibitors